18 Multidisciplinary Management of Cancersmulticancers.org/documents/MMJ18026_FINALBROCHURE.pdf ·...
Transcript of 18 Multidisciplinary Management of Cancersmulticancers.org/documents/MMJ18026_FINALBROCHURE.pdf ·...
18th Multidisciplinary Management of Cancers:A CASE-BASED APPROACHSPONSORED BY the Association of Northern California Oncologists, Stanford Cancer Institute, UC Davis Comprehensive Cancer Center, and UCSF Helen Diller Family Comprehensive Cancer Center.
2018 TUMOR BOARD CASES AND PANELS
March 16-18, 2018Silverado Resort & SpaNapa, California
• Breast Cancer• Central Nervous System Cancers• Developmental Therapeutics• Gastrointestinal Cancers
• Genitourinary Cancers• Head and Neck/Thyroid Cancers• Hematologic Malignancies• Lymphoma
• Melanoma• Palliative Care• Sarcoma• Thoracic Cancer
CONFERENCE INFORMATION
Multidisciplinary Management of Cancers:A Case-based Approach
CONFERENCE DESCRIPTIONThis conference will present the most current information on multidisciplinary approaches in clinical oncology and will consist of tumor board cases on breast, central nervous system, gastrointestinal, genitourinary, head and neck/thyroid, hematologic malignancies, lymphoma, melanoma, sarcoma, and thoracic cancers as well as developmental therapeutics and palliative care. The tumor board cases will be presented by faculty, with discussion by a panel of surgical, radiation, and medical oncologists from Stanford, UC Davis, UC San Francisco, and the practice community.
TARGET AUDIENCEThis course is designed for physicians specializing in medical, surgical, and radiation oncology as well as nurses, pharmacists, and other allied health professionals who work with cancer patients.
STATEMENT OF EDUCATIONAL NEED Because the standard of care in oncology changes rapidly with new discoveries, there is a need for frequent updates of practical relevance for the practicing oncologist. This conference will emphasize standard of care issues for various cancers including diagnostic and therapeutic decision-making and optimal approaches to supportive and palliative care. The faculty at the Stanford Cancer Institute, UC Davis Comprehensive Cancer Center, and UCSF Helen Diller Family Comprehensive Cancer Center put a premium on optimal multidisciplinary modeling treatment and education of the practicing oncologist to ensure they are up to date. The American Society for Clinical Oncology recommends this multidisciplinary meeting format. This symposium and its faculty specifically address the clinical guidelines set forth by the National Comprehensive Cancer Network.
LEARNING OBJECTIVESAt the conclusion of this activity, participants will be able to:1. Develop multidisciplinary treatment strategies based on
national clinical practice guidelines in oncology in order to improve quality of care for cancer patients.
2. Discuss relevant clinical trials with cancer patients and refer appropriately.
CONFERENCE FORMATThe format of the conference is oriented around tumor board cases. We will use an interactive group response system with an electronic keypad for each participant during the case discussions. We encourage you to submit cases for discussion.
CALL FOR CASE SUBMISSIONSRegistrants are encouraged to submit a case or cases for the panels to discuss. Deadline for case submissions is Friday, December 29, 2017. The organizing committee and panel chairs will select cases. Please visit the course website for the case submission form: www.multicancers.org.
ACCREDITATION AND CREDIT DESIGNATIONPhysicians. The University of California, San Francisco, Office of Continuing Medical Education is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
The University of California, San Francisco, Office of Continuing Medical Education designates this live activity for a maximum of 19.00 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Nurses. The California Board of Registered Nursing recognizes that Continuing Medical Education (CME) is acceptable for meeting RN continuing education requirements, as long as the course is certified for AMA PRA Category 1 Credits™ (rn.ca.gov). Nurses will receive a Certificate of Attendance following this activity that may be used for license renewal.
Physician Assistants. AAPA accepts category 1 credit from ACCME, Prescribed credit from AMA category 1 credit forthe PRA for organizations accredited by the ACCME.
FACULTY DISCLOSURE The University of California, San Francisco, Office of Continuing Medical Education adheres to ACCME Essential Areas, Standards, and Policies regarding industry support of continuing medical education. Disclosure of faculty and commercial relationships will be made prior to the activity.
PLANNING COMMITTEEA. Dimitrios Colevas, MD (Conference Co-Director)David Gandara, MD (Conference Co-Director)Margaret Tempero, MD (Conference Co-Director) Courtney Flookes and Jose Luis Gonzalez (Conference Planners)
Tell a colleague! To register online go to: www.multicancers.org 2
MESSAGE SCHEDULEfrom the Co-Directors
Dear Colleagues,
It is a pleasure for us to invite you to the 18th
Multidisciplinary Management of Cancers meeting to be
held March 16-18, 2018. The 2018 program represents
a collaborative effort of expert clinicians from the
Stanford Cancer Institute, University of California,
Davis, University of California, San Francisco, and the
Association of Northern California Oncologists.
Based on the recurrent enthusiasm for a case oriented
approach we once again will be tackling some of
the toughest cases, heavily relying upon audience
participation and feedback. Community oncologists
will be represented on the panels as well. With that
in mind, we remind you that we look forward to your
submission of real cases to discuss. Using our online
case submission form, please submit cases for us by the
end of December 2017. We will select cases from among
those submitted for presentation.
Our primary goal of this meeting, as always, is to
provide learners with the latest developments in the
multidisciplinary management of cancers.
Space is limited so register early. We look forward to
your participation at this meeting.
Sincerely,
FRIDAY, MARCH 16, 20187:30–8:30 Registration and Continental Breakfast
8:30–8:45 Welcome and Opening Remarks
8:45–10:45 Breast Cancer Tumor Board Cases Melinda L. Telli, MD, Stanford – CHAIR
Michael Alvarado, MD, UC San Francisco
Richard J. Bold, MD, UC Davis
Helen K. Chew, MD, UC Davis
Jo Chien, MD, UC San Francisco
Joshua Gruber, MD, Stanford
Suleiman Massarweh, MD, Stanford
Hope S. Rugo, MD, UC San Francisco
Candice Sauder, MD, UC Davis
Tiffany Svahn, MD, Diablo Valley Oncology & Hematology Medical Group
Irene Wapnir, MD, Stanford
10:45–11:00 Break
11:00–12:00 Head and Neck/Thyroid Cancers Tumor Board Cases
A. Dimitrios Colevas, MD, Stanford – CHAIR
Alain Algazi, MD, UC San Francisco
Michael Campbell, MD, UC Davis
Chrysoula Dosiou, MD, Stanford
Quad-Yang Duh, MD, UC San Francisco
Jed Katzel, MD, The Permanente Medical Group
Lisa Orloff, MD, Stanford
Shyam Rao, MD, PhD, UC Davis
Jonathan Riess, MD, MS, UC Davis
Tanaya Shree, MD, Stanford
12:00–1:00 Lunch
1:00–3:00 Hematologic Malignancies Tumor Board Case
Brian A. Jonas, MD, PhD, UC Davis – CHAIR
Jason Gotlib, MD, MS, Stanford
Rajeev Krishnan, MD, UC Davis
Gabriel Mannis, MD, UC San Francisco
Thomas Martin, MD, UC San Francisco
Bruno Medeiros, MD, Stanford
Aaron Rosenberg, MD, UC Davis
Neil Shah, MD, PhD, UC San Francisco
Shahzad Siddique, MD, Dignity Health
Hyma Vempathy, MD, The Permanente Medical Group
3:00–3:15 Break
3:15–5:15 Thoracic Cancer Tumor Board CasesMatthew A. Gubens, MD, MS, UC San Francisco –CHAIR
Colin Blakely, MD, PhD, UC San Francisco
Gigi Chen, MD, Diablo Valley Oncology & Hematology Medical Group
David Cooke, MD, UC Davis
Megan Daly, MD, UC Davis
Maximilian Diehn, MD, Stanford
David Gandara, MD, UC Davis
David Jablons, MD, UC San Francisco
Thierry Jahan, MD, UC San Francisco
Julia Rotow, MD, UC San Francisco
Joseph B. Shrager, MD, Stanford
3
A. Dimitrios Colevas, MD Conference Co-Director Professor of Medicine (Oncology)
and by courtesy, Otolaryngology, Head and Neck Surgery,
Stanford University School of Medicine
David Gandara, MD Conference Co-Director Thoracic Oncology Program, UC Davis Health System;
Professor, UC Davis Medical School;
Senior Advisor to Director, UC Davis Comprehensive
Cancer Center
Margaret Tempero, MD Conference Co-Director Director, UCSF Pancreas Center;
Leader, Pancreas Cancer Program,
Professor of Medicine, Division of Hematology and
Oncology, UC San Francisco
4
SCHEDULE
3:15–5:15 Thoracic Cancer Tumor Board Cases, CONT.Jennifer Marie Suga, MD, The Permanente Medical Group
Heather Wakelee, MD, Stanford
5:15 Adjourn
6:00–7:30 Welcome Reception
SATURDAY, MARCH 17, 20188:00–8:30 Continental Breakfast
8:30–8:45 Welcome and Opening Remarks
8:45–10:15 Lymphoma Tumor Board Cases Lawrence Kaplan, MD, UC San Francisco – CHAIR
Ranjana Advani, MD Stanford
Charalambos (Babis) Andreadis, MD,
UC San Francisco
Jarrod Holmes, MD, Annadel Medical Group
Richard Hoppe, MD, Stanford
Youn Kim, MD, Stanford
Vu Nguyen, MD, The Permanente Medical Group
Leena Rahmat, MD, UC San Francisco
Joseph Tuscano, MD, UC Davis
10:15–10:30 Break
10:30–12:00 Melanoma Tumor Board Cases
Scott Christensen, MD, UC Davis – CHAIR
Adil Daud, MD, UC San Francisco
Julian Davis, MD, UC Davis
Amanda Kirane, MD, UC Davis
David Minor, MD, California Pacific Medical Center Research Institute
Sunil Reddy, MD, Stanford
Susan Swetter, MD, Stanford
Thach-Giao Truong, MD, The Permanente Medical Group
Katy Tsai, MD, UC San Francisco
12:00–1:00 Lunch
1:00–2:30 Genitourinary Cancers Tumor Board Cases
Sandy Srinivas, MD, Stanford – CHAIR
Alexey Aleshin, MD, Stanford
Peter Carroll, MD, UC San Francisco
Benjamin Chung, MD, Stanford
Natalia Colocci, MD, Palo Alto Medical Foundation
Terence Friedlander, MD, UC San Francisco
Andrea Harzstark, MD, The Permanente Medical Group
Chong-Xian Pan, MD, PhD, UC Davis
Eila Skinner, MD, Stanford
Richard Valicenti, MD, UC Davis
2:30–2:45 Break
2:45–4:15 Developmental TherapeuticsShivaani Kummar, MD, Stanford – CHAIR
Rahul Aggarwal, MD, UC San Francisco
Mrinal Dutia, MD, The Permanente Medical Group
Karen Kelly, MD, UC Davis
Tianhong (Tina) Li, MD, PhD, UC Davis
Pamela Munster, MD, UC San Francisco
2:45–4:00 Developmental Therapeutics, CONT.Srikanth Reddy, MD, EPIC Care
Branimir I. (Brandy) Sikic, MD, Stanford
Diane Tseng, MD, Stanford
4:00 Adjourn
6:30–7:30 Cocktail Hour
SUNDAY, MARCH 18, 20188:00–8:30 Continental Breakfast
8:30–8:45 Welcome and Opening Remarks
8:45–10:15 Gastrointestinal Cancers Tumor Board Cases Edward Kim, MD, PhD, UC Davis – CHAIR
Daniel Chang, MD, Stanford
May Cho, MD, UC Davis
Naseem Esteghamat, MD, UC Davis
George A. Fisher, MD, PhD, Stanford
Sisi Haraldsdottir, MD, Stanford
Kenzo Hirose, MD, UC San Francisco
Andrew Ko, MD, UC San Francisco
Arta Monjazeb, MD, PhD, UC Davis
George Poultsides, MD, Stanford
Thomas Semrad, MD, Tahoe Forest Cancer Center
Margaret Tempero, MD, UC San Francisco
Alan Venook, MD, UC San Francisco
10:15–10:30 Break
10:30–12:00 Central Nervous System Cancers Tumor Board Cases Ruben Fragoso, MD, UC Davis – CHAIR
Michael Cardenas, MD, UC Davis
Gordon Li, MD, Stanford
Seema Nagpal, MD, Stanford
Scott Peak, MD, The Permanente Medical Group
Jennie Taylor, MD, UC San Francisco
12:00–1:00 Lunch
1:00–2:30 Sarcoma Tumor Board CasesRosanna Wustrack, MD, UC San Francisco – CHAIR
Raffi Avedian, MD, Stanford
Robert Canter, MD, UC Davis
Scott Christensen, MD, UC Davis
Kristen Ganjoo, MD, Stanford
Thierry Jahan, MD, UC San Francisco
Lynn Million, MD, Stanford
Ross Okimoto, MD, UC San Francisco
Ming-Gui Pan, MD, The Permanente Medical Group
2:30–2:45 Break
2:45–4:15 Palliative Care Tumor Board CasesMichael Rabow, MD, UC San Francisco – CHAIR
Michael Fratkin, MD, Resolution Care
Stephanie Harman, MD, Stanford
Frederick Meyers, MD, UC Davis
Kavitha Ramchandaran, MD, Stanford
Kai Romero, MD, UC San Francisco
Piyush Srivastava, MD, The Permanente Medical Group
4:15 Adjourn
Panelists have been invited; program subject to change. Opportunities for Q&A will be provided during each panel.
5
REGISTER
REGISTRATIONRegistration includes course materials, continental breakfast each day, lunch on Friday, Saturday and Sunday, a hosted welcome reception on Friday evening, and cocktail hour on Saturday evening.
ANCO MD Members: $500
Other MD, PhD, PharmD: $525 Early Bird – Registration before 2/1/18
$575 Registration 2/1/18–2/28/18
$625 Late Registration 3/1/18–3/09/18
Nurses/Allied Health: $375 Early Bird – Registration before 2/1/18
$425 Registration 2/1/18–2/28/18
$475 Late Registration 3/1/18–3/09/18
Trainees and students: $125
Industry MD, PhD, $675 Early Bird – Registration before 2/1/18
PharmD, MSL: $725 Registration 2/1/18–2/28/18
$775 Late Registration 3/1/18–3/09/18
Industry Representatives: $800 Early Bird – Registration before 2/1/18
$825 Registration 2/1/18–2/28/18
$850 Late Registration 3/1/18–3/09/18
To register, please go online to www.multicancers.org
ACCEPTED METHODS OF PAYMENTCredit Card (Visa, Mastercard, or American Express) – Register online at www.multicancers.org. If you prefer to pay by phone or check, please contact the University of California, San Francisco, Office of Continuing Medical Education at 415-476-5808 for assistance (note that your registration is not confirmed until payment is received).
Online registration closes at end of business day on 3/09/18. Registration will open onsite the day of the conference if space is available. A $75 onsite registration fee will be added to all onsite registrations. Course materials are not guaranteed for onsite registrants.
CANCELLATION POLICYAll cancellations must be made in writing and sent to University of California, San Francisco, Office of Continuing Medical Education, 3333 California Street, Suite 450, San Francisco, CA 94118, or [email protected]. Registration fee, less a $50 administrative charge is refundable if written cancellation is received prior to March 2, 2018. No refunds will be given for cancellations received after this date or for conference non-attendance. We reserve the right to cancel or postpone any activity if necessary. In such case, full refund of registration fee will be given. We are not responsible for other costs incurred such as non-refundable airline tickets or hotel penalties.
CONTACT INFORMATIONFor questions concerning registration or meeting logistics, please contact:
UCSF Office of CME3333 California Street, Suite 450San Francisco, CA 94118415-476-5808 • [email protected]
UCSF Office of CME is fully ADA compliant. If you have needs that require special accommodations, including dietary concerns, please contact [email protected] before March 2, 2018.
0569University of California,San FranciscoOffice of ContinuingMedical EducationUCSF Box 0742San Francisco, CA94143-0742
Conference Information continued...
CONFERENCE LOCATIONSilverado Resort & Spa
1600 Atlas Peak Road • Napa, California 94558 tel: 707.257.0200
For driving directions and maps, please visit silveradoresort.com/directions
SILVERADO RESORT CONTACT INFORMATION
Silverado Reservations: 1.800.532.0500
Spa Reservations: (707)-257-5555 • Golf Reservations: (707) 257-5460
ACCOMMODATIONSA block of rooms has been reserved at a reduced rate at the Silverado Resort and Spa. Resort guestrooms are available at the rate of $195; junior suites are available at the rate of $235; and, one-bedroom suites are available at the rate of $265 plus tax and resort fees per night (single or double occupancy).
Room reservations should be made directly with the Silverado Resort and Spa and as early as possible. The ‘Multidisciplinary Management of Cancers’ room block rates will only be available until Tuesday, February 3, 2018. After this date, reservations will be accepted on a space available basis and at regular resort rates.
Please go to https://aws.passkey.com/go/Multicancer to make your hotel reservations or call 1.800.532.0500.
VISITING NAPA & RESTAURANTSThe Napa Valley is world renown as being a premier destination to visit for wineries, golf, arts and culture as well as its famous culinary scene. To discover things to do and restaurants to visit in the Valley, please go to www.visitnapavalley.com.